Meeting Banner
Abstract #3930

Brain Tumour Studies using Low-Dose Gadolinium-Based Contrast Agent Dynamic Contrast Enhancement MRI

Xiaoping Zhu1, Daniel Lewis2, Ka-Loh Li1, and Alan Jackson1
1DIIDS, University of Manchester, Manchester, United Kingdom, 2Department of Neurosurgery, Salford Royal NHS Foundation Trust, Manchester, United Kingdom

Synopsis

Using one-fifth of standard GBCA dose, high spatial resolution (LDHS) whole brain pharmacokinetic maps was calculated and compared with those from dual temporal resolution (DTR) DCE, which combines high temporal resolution (LDHT) and full dose spatial resolution DCE. Results from Monte Carlo simulation suggested the measurement uncertainty and bias reduced to negligible whilst CNR of tumour concentration curves is greater than 3.1. The in-vivo LDHS maps have compatible accuracy with those from HT DCE, moreover revealing tumor heterogeneity to the quality DTR have achieved. Largely reduced dose enabled safer exams for patients undergoing repeated administration of GBCA.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords